chuminhua2020-06-01 20:30
5/30,Menlo Therapeutics公司$Menlo Therapeutics(MNLO)$ 宣布,美国FDA已批准其全资子公司Foamix Pharmaceuticals开发的米诺环素局部疗法Zilxi(1.5% minocyline,FMX103)上市,治疗酒渣鼻成人患者。新闻稿指出,Zilxi是首款获得美国FDA批准治疗酒渣鼻成人患者的米诺环素局部疗法。Zilxi是该公...查看全文
$Menlo Therapeutics(MNLO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-018213 Size: 10 KB 网页链接
$Menlo Therapeutics(MNLO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-018214 Size: 11 KB 网页链接
$Menlo Therapeutics(MNLO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-018215 Size: 11 KB 网页链接
$Menlo Therapeutics(MNLO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-018216 Size: 11 KB 网页链接
$Menlo Therapeutics(MNLO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-018217 Size: 11 KB 网页链接
$Menlo Therapeutics(MNLO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-018218 Size: 11 KB 网页链接
$Menlo Therapeutics(MNLO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-018219 Size: 11 KB 网页链接
$Menlo Therapeutics(MNLO)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.03, 5.01, 5.02, 8.01, and 9.01 Accession Number: 0001104659-20-030847 Act: 34 Size: 433 KB 网页链接
$Menlo Therapeutics(MNLO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-20-030838 Act: 33 Size: 103 KB 网页链接
$Menlo Therapeutics(MNLO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-20-008442 Act: 34 Size: 10 MB 网页链接